InvestorsHub Logo
Followers 50
Posts 12099
Boards Moderated 0
Alias Born 06/15/2014

Re: sts66 post# 50314

Thursday, 05/28/2015 4:44:06 PM

Thursday, May 28, 2015 4:44:06 PM

Post# of 431876
One thing that stands out to me in the PR is how Vascepa is described. Very carefully described as:

"a significant and novel treatment option in the management of severely high triglycerides".

Not pushing any limits there for sure. Maybe still don't want to piss of the FDA any more than the punch in the nose they got today!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News